Celldex Therapeutics Inc (NASDAQ:CLDX)

2.35
Delayed Data
As of Feb 16
 +0.04 / +1.73%
Today’s Change
2.20
Today|||52-Week Range
3.94
-17.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash42.5M42.5M66.2M54.7M
 
 
 
 
 
Short Term Investment Cash10.7M36.0K23.7M-11.4M
 
 
 
 
 
Cash & Short Term Investments189.2M166.5M153.6M140.2M
 
 
 
 
 
 
ReceivablesReceivables2.4M1.9M1.8M3.3M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.0M5.1M4.7M3.8M
 
 
 
 
 
Current Assets195.6M173.5M160.1M147.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross33.2M------
 
 
Depreciation-20.0M------
 
 
Intangible Assets172.5M172.2M172.0M158.8M
 
 
 
 
 
Other Assets174.6M174.2M174.0M160.8M
 
 
 
 
 
Total Assets383.4M360.0M346.1M319.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.7M2.7M2.0M1.3M
 
 
 
 
 
Accrued Expenses21.5M19.4M21.3M17.8M
 
 
 
 
 
Other Current Liabilities26.4M24.4M26.8M23.6M
 
 
 
 
 
Other Liabilities35.2M27.0M28.8M24.9M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities82.7M85.2M85.8M75.4M
 
 
 
 
 
Total Liabilities117.9M112.2M114.6M100.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity265.4M247.8M231.5M219.2M
 
 
 
 
 
Total Shareholder Equity265.4M247.8M231.5M219.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding120.5M124.2M127.4M132.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.